Evidence map›Paper›PMID 35475609›Full record

ReviewJournal of natural products2022

Clerodane Diterpenes from

Nova Syafni, Maria Teresa Faleschini, Aleksandra Garifulina, Ombeline Danton, Mahabir P Gupta, Steffen Hering, Matthias Hamburger

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of natural products, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 4 countries.

Nova SyafniPharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
Maria Teresa FaleschiniPharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
Aleksandra GarifulinaDivision of Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Vienna, Pharmaziezentrum, Althanstrasse 14, 1090 Vienna, Austria.
Ombeline DantonPharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
Mahabir P GuptaCenter for Pharmacognostic Research on Panamanian Flora, Faculty of Pharmacy, University of Panama, Panama City 0801, Panama.
Steffen HeringDivision of Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Vienna, Pharmaziezentrum, Althanstrasse 14, 1090 Vienna, Austria.
Matthias HamburgerPharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.ORCID 0000-0001-9331-273X
University of Basel · CHUniversity of Vienna · ATUniversidad de Panamá · PA

Funding

Austrian Science Fund FWF W 1232
6 · The paper itself

Abstract

An EtOAc extract of

Indexed as

CaseariaDiterpenes, ClerodaneAnimalsBenzodiazepinesCHO CellsCricetinaeCricetulusFlumazenilGABA Modulatorsgamma-Aminobutyric AcidOocytesReceptors, GABA-AXenopus laevisBenzodiazepinesDiterpenes, ClerodaneFlumazenilGABA Modulatorsgamma-Aminobutyric AcidReceptors, GABA-A

Identifiers

PMID35475609
PMCPMC9150179
OpenAlexW4225005354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.